Skip to the main content.
Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Turn Our Insights Into Your Impact

From early feasibility to commercialization, progress depends on the right decisions at the right time. Get confident in your next step with blogs, case studies, and expert insights that cut through complexity and move development forward.

 

1 min read

Voices of Veranex | Jessica Amilcar: Preclinical 24/7 ICU Care

Voices of Veranex | Jessica Amilcar: Preclinical 24/7 ICU Care

The Impact of 24/7 ICU Monitoring on Research Success

Discover how continuous care transforms study outcomes and can be a key differentiator for complex programs.

In the realm of veterinary research, the value of continuous 24/7 ICU monitoring cannot be overstated. Jessica Amilcar, Director of Preclinical Veterinary Research at Varenex, sheds light on how this practice enhances study integrity and outcomes.

Key Takeaways:

  • The Shift from Reactive to Proactive Care: Enable early identification of adverse trends, ensuring greater physiological stability and reduce unexpected events that could compromise study results with continuous 24/7 ICU monitoring. Traditional studies cause reactionary care due to observations occurring at predetermined intervals, potentially allowing for undetected physiological deterioration.

  • Key Parameters at Risk: Detection of early hypertension, chemodynamic instability, progressive hypoxemia, and circuit flow changes are common critical parameters Jessica points out that are often missed without dedicated ICU care. These factors can threaten both the scientific validity of studies and the confidence of regulatory entities in reviewing protocols.

  • Advantages of Continuous Monitoring: Continuous monitoring generates cleaner, more interpretable data sets by minimizing preventable complications resulting benefits extending beyond immediate care to improve regulatory submission reviews and approval rates.

  • Final Thoughts: The insights shared by Jessica Amilcar highlight the transformative potential of 24/7 ICU care in veterinary research. As the field continues to evolve, embracing proactive monitoring practices will be crucial for advancing study success and ensuring the highest quality of care.

For a deeper understanding, listen to the full episode where Jessica elaborates on these critical insights.